Professor Fidelma Dunne is happy to announce that the REDEFINE 2 study has commenced and will be recruiting people on to the study.
The REDEFINE study is a randomised, placebo-controlled trial and will be investigating how well a new medicine, called CagriSema, works at lowering body weight versus the placebo.
In addition to taking the medicine, you will have talks with study staff about the study medicine, healthy food choices, to help you be more physically active, eat healthier and lose weight.
The study staff will explain the process to you in detail before you decide to participate.
Participation in a clinical study often means more visits to the clinic and more medical tests than you would normally have. The study staff may also call you between visits.